DSDolly Singh

Dolly Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dolly Singh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Deepti Singh

    Biomaterials Lab, Department of Nano, Medical & Polymer Materials, College of Engineering, Yeungnam University, 280 Daehak-ko, Gyeongsan, Gyeongsangbuk-do 712-749, Republic of Korea

    2 shared publications
  • Soon Mo Choi

    Biomaterials Lab, Department of Nano, Medical & Polymer Materials, College of Engineering, Yeungnam University, 280 Daehak-ko, Gyeongsan, Gyeongsangbuk-do 712-749, Republic of Korea

    2 shared publications
  • Sun Mi Zo

    Biomaterials Lab, Department of Nano, Medical & Polymer Materials, College of Engineering, Yeungnam University, 280 Daehak-ko, Gyeongsan, Gyeongsangbuk-do 712-749, Republic of Korea

    2 shared publications
  • Sung Soo Han

    School of Chemical Engineering, Yeungnam University

    2 shared publications
  • Aviral Chaudhary

    1 shared publication
  • Eun Mi Lee

    Department of Life Sciences, Yeungnam University, Gyeongsan, Gyeongsangbuk-do 712-749, Republic of Korea

    1 shared publication

Latest Publications

  • Mass management system for Covid-19 monitoring and managing the crowd

    by Praveen Yadav, Aviral Chaudhary, Dolly Singh, Sachin Kumar, Swatika Srivastava

    As the Covid pandemic (Covid-19) spreads, so do innovative applications and drives pointed toward forestalling infection spread, treating patients, diminishing strain on exhausted experts, and growing new, viable immunisations. Whenever everybody needs better data, including plague infection experts, state specialists, global associations, and individuals in isolation or keeping social separation, computerised data and reconnaissance innovations have been released in an uncommon way to gather information and dependable proof to help general wellbeing navigation. As researchers competition to create and test future antibodies utilising quality altering, manufactured science, and nanotechnologies, man-made brainpower, advanced mechanics, and robots will be utilised to follow the infection and authorise severe controls.

  • Open Access

    Novel Alginate‐Gelatin Hybrid Nanoparticle for Drug Delivery and Tissue Engineering Applications

    by Eun Mi Lee, Deepti Singh, Dolly Singh, Soon Mo Choi, Sun Mi Zo, Seon Joo Park, Sung Soo Han

    Novel alginate‐gelatin hybrid nanoparticles were fabricated using single oil in water (O/W) emulsification techniques. Physicochemical property of the particle was characterized using scanning electron microscopy and Fourier’s transmission infrared spectroscopy. Particle size was determined using zeta potential metastasize analyzer and was found to be in range of 400–600 nm. AGNPs were used for culturing human keratinocytes for two weeks to check biocompatibility of synthesized AGNPs. 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay showed increased metabolic activity of cells cultured on AGNPs in comparison to two‐dimensional (2D) system (control). Cellular attachment on nanoparticle was further confirmed using SEM and 4′,6‐diamidino‐2‐phenylindole staining. The drug release profile shows possible electrostatic bond between alginate and gelatin resulting in controlled release of drug from AGNPs. For the first time alginate‐gelatin hybrid nanosystem has been fabricated and all results showed it can be used as potential system for delivery of drug and therapeutical agents to cells and can also be used for regenerative medicine applications.


  • Open Access

    Effect of Extracts of Terminalia chebula on Proliferation of Keratinocytes and Fibroblasts Cells: An Alternative Approach for Wound Healing

    by Dolly Singh, Deepti Singh, Soon Mo Choi, Sun Mi Zo, Rakesh Mohan Painuli, Sung Won Kwon, Sung Soo Han

    Terminalia chebula is one of the traditional medicines used in the treatment of many diseases. In the present work, different concentrations of various organic and aqueous extracts (solvent‐free) of T. chebula were tested on fibroblast (L929) and keratinocytes cells to evaluate its biocompatible concentration by using MTT and live‐dead viability/cytotoxic assay. These extracts were found to be effective in decreasing the ammonia accumulation in the media, thereby reducing its toxic effect on cells. DPPH assay further confirmed the free‐radical scavenging ability of the extracts which increased with the increase in concentration of each extract. Cell proliferation/apoptosis, cytoskeletal structure, and ECM production were further evaluated by live‐dead assay and phalloidin/cytokeratin staining, respectively. The cytoskeletal structure and ECM secretion of the cells treated with extracts showed higher cellular activity in comparison to control. In conclusion, we have demonstrated the effect of these extracts of T. chebula on both types of skin cells and optimized concentration in which it could be used as a bioactive component for wound healing applications by increasing cell proliferation and decreasing free‐radical production without affecting the normal cellular matrix. It can also find applications in other therapeutics applications where ammonia toxicity is a limiting factor.